Method to Determine Contrast Media Injection Parameters to Control Signal Intensity During Magnetic Resonance Angiography

Patent №

US 9,744,289

Granted

2017-08-29

Filed 2013

Owner

MALLINCKRODT INC.

+1 more

Lab

AI components

1

vision

Assignment

Recorded

Dataset

AIPD

2023_r1 edition

Application

14003893

Injection systems and related methods including an injection device, an operator interface, and modules to determine operational parameters during an MRA imaging procedure. Such parameters may be used to optimize and/or maximize signal intensity during an MRA imaging procedure. The injection system may include a target in-bloodstream contrast agent concentration determination module that determines a target in-bloodstream contrast agent concentration at least partially based on contrast agent type and MRA imager parameters. The injection system may include a contrast agent injection rate determination module that determines a contrast agent injection rate at least partially based on the target in-bloodstream contrast agent concentration, an initial contrast agent concentration, and a cardiac output rate of a patient to be imaged. The injection system may include a diluent injection rate determination module that determines a diluent injection rate at least partially based on the contrast agent injection rate.

VisionA61M 5/007A61B 5/055A61M 5/1452A61M 5/14546A61M 2005/14553

AI classification

Vision0.84
AI hardware0.24
Evolutionary computation0.10
Knowledge representation0.07
Machine learning0.01
Natural language0.00
Planning0.00
Speech0.00

Ownership

MALLINCKRODT INC.

assignment · 311640315

LIEBEL-FLARSHEIM COMPANY LLC

assignment · 347150531

Assignors

HYNES, MICHAEL R., MOORE, DENNIS A., NEUBERT, WILLIAM J.

On an employer assignment, the assignors are typically the inventors.

© 2026 NYSGPT2525 LLC